Dr. Muller Fabbri is Associate Professor and co-Leader of the Cancer Biology Program at the University of Hawai'i Cancer Center (UHCC) in Honolulu, HI, USA. He also is the Scientific Lead of the Micro- and Nano-Scale Cancer Therapeutics Initiative at UHCC. Dr. Fabbri has provided the first evidence that microRNAs delivered to surrounding cells of the Tumor Microenvironment through extracellular vesicles can bind to Toll-like receptors and trigger downstream signaling pathways highly impactful on cancer biology. Dr. Fabbri is author of more than 90 peer reviewed publications, he has authored several book chapters, serves in the Editorial Board of many international scientific Journals. Dr. Fabbri's lab is focused on studying how microRNAs (and other non-coding RNAs) are communicating between cancer cells and surrounding cells of the tumor microenvironment and how this affects cancer biology and the development of resistance to chemo and radiotherapy.